How big is the Vaccine Contract Manufacturing Market?

The Vaccine Contract Manufacturing Market size is expected to reach USD 3.51 billion in 2024 and grow at a CAGR of 11.18% to reach USD 5.98 billion by 2029. Read More

What is the current Vaccine Contract Manufacturing Market size?

In 2024, the Vaccine Contract Manufacturing Market size is expected to reach USD 3.51 billion. Read More

Who are the key players in Vaccine Contract Manufacturing Market?

Ajinomoto Bio-Pharma Services, Curia Global, Charles River Laboratories International Inc., Emergent BioSolutions Inc. and IDT Biologika GmbH are the major companies operating in the Vaccine Contract Manufacturing Market. Read More

Which is the fastest growing region in Vaccine Contract Manufacturing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Vaccine Contract Manufacturing Market?

In 2024, the North America accounts for the largest market share in Vaccine Contract Manufacturing Market. Read More

What years does this Vaccine Contract Manufacturing Market cover, and what was the market size in 2023?

In 2023, the Vaccine Contract Manufacturing Market size was estimated at USD 3.16 billion. The report covers the Vaccine Contract Manufacturing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Vaccine Contract Manufacturing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Vaccine Contract Manufacturing Companies

This report lists the top Vaccine Contract Manufacturing companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Vaccine Contract Manufacturing industry.